InvestorsHub Logo
Followers 827
Posts 119554
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Tuesday, 03/29/2022 4:22:15 PM

Tuesday, March 29, 2022 4:22:15 PM

Post# of 27
PRDS 4Q21 financials—12/31/21 cash=$269M:

https://finance.yahoo.com/news/pardes-biosciences-reports-full-2021-200500575.html

4Q21 was PRDS’ first quarter as a public company following a SPAC merger on 12/23/21 (https://www.globenewswire.com/news-release/2021/12/27/2358007/0/en/Pardes-Biosciences-Debuts-as-a-Publicly-Traded-Company-Focused-on-Oral-Antiviral-Therapies-to-Potentially-Treat-and-Prevent-COVID-19.html ). Essentially all of the cash on hand at 12/31/21 came from the SPAC and a $75M PIPE at $10/sh that was executed concurrently with the merger.

No CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRDS News